The Role of c-MET as a Biomarker in Patients with Bladder Cancer Treated with Radical Chemo-Radiotherapy

The Role of c-MET as a Biomarker in Patients with Bladder Cancer Treated with Radical Chemo-Radiotherapy

Background: Bladder cancer is a highly aggressive cancer, and muscle invasive urothelial carcinoma (MIUC) requires aggressive strategy. Concomitant chemo-radiotherapy (CRT) appears as a therapeutic option that allows bladder sparing. No biomarker is currently available to optimally select patients f...

Full description

Bibliographic Details
Main Authors: Hélène Houssiau, Géraldine Pairet, Hélène Dano, Emmanuel Seront
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Current Oncology
Subjects:
c-MET
bladder cancer
radiotherapy
chemotherapy
metastasis-free survival
biomarker
Online Access:https://www.mdpi.com/1718-7729/30/12/770

Similar Items

Similar Items